Codexis (FRA:4QK) Buyback Yield % : -16.37 (As of Apr. 11, 2025)

View and export this data going back to 2010. Start your Free Trial

What is Codexis Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Codexis's current buyback yield was -16.37%.

Codexis Buyback Yield % Historical Data

The historical data trend for Codexis's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Buyback Yield % Chart

Codexis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-6.13

-4.03

-7.67

Codexis Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															-4.06	-2.89	-	-	-8.02

Competitive Comparison of Codexis's Buyback Yield %

For the Biotechnology subindustry, Codexis's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Codexis's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codexis's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Codexis's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Codexis Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Codexis's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	29.91)	/	390.0971
	=	-7.67%

Codexis's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	29.91)		/	390.0971
	=	-7.67%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Codexis Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Codexis's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Codexis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (FRA:4QK) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

CDXS:USA 0I0X:UK 4QK:Germany

Address

200 Penobscot Drive, Redwood City, CA, USA, 94063

Website

https://www.codexis.com

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Codexis Headlines

No Headlines